CLAIM #27317 · GILD (GILD) · 2025Q3 earnings call · Oct 30, 2025 · due Dec 31, 2028
“this is expected to support a regulatory filing with potential for approval in 2028.”
Dietmar Berger · Chief Medical Officer
PENDING
graded after results covering Dec 31, 2028 are reported
How to check this claim
Look at: Regulatory approval status of the product/indication referenced by the filing
It came true if: Regulatory approval (e.g., FDA/EMA) granted on or before 2028-12-31
Where: Company press release or FDA/EMA approval database; company-disclosed regulatory filings (10-K/10-Q or press releases)
Verify independently
SEC filings for GILD ↗ · Claim quote is verbatim from the 2025Q3 earnings call.